GS0421: Pharmaceutical research and development; Research and development in the field of pharmaceuticals for the treatment of human diseases of the respiratory, [ endocrine, ] circulatory, gastrointestinal, genitourinary and central nervous system, [for the treatment of] [ cancer and ] [pain and for use as anti-infectives;] Research and development in the field of bi-functional and multibinding compounds for use as a component of pharmaceutical preparations
Case File Event Statements
1/15/2022 - 4 years ago
20 - NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILEDType:NA89
1/15/2022 - 4 years ago
19 - REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)Type:RNL1
1/15/2022 - 4 years ago
18 - REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTEDType:89AG
1/15/2022 - 4 years ago
17 - CASE ASSIGNED TO POST REGISTRATION PARALEGALType:APRE
8/6/2021 - 4 years ago
16 - TEAS SECTION 8 & 9 RECEIVEDType:E89R
9/23/2017 - 8 years ago
15 - NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - MAILEDType:NA85
9/23/2017 - 8 years ago
14 - REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.Type:C15A
9/22/2017 - 8 years ago
13 - CASE ASSIGNED TO POST REGISTRATION PARALEGALType:APRE
8/17/2017 - 8 years ago
12 - TEAS SECTION 8 & 15 RECEIVEDType:E815
6/25/2014 - 11 years ago
11 - AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIPType:ASGN